139 related articles for article (PubMed ID: 9141445)
1. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.
Zibert A; Meisel H; Kraas W; Schulz A; Jung G; Roggendorf M
Hepatology; 1997 May; 25(5):1245-9. PubMed ID: 9141445
[TBL] [Abstract][Full Text] [Related]
2. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
Zibert A; Schreier E; Roggendorf M
Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
[TBL] [Abstract][Full Text] [Related]
3. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
Lechner S; Rispeter K; Meisel H; Kraas W; Jung G; Roggendorf M; Zibert A
Virology; 1998 Apr; 243(2):313-21. PubMed ID: 9568031
[TBL] [Abstract][Full Text] [Related]
4. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
[TBL] [Abstract][Full Text] [Related]
6. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
Zhou YH; Sugitani M; Esumi M
Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
8. Influence of specific CD4+ T cells and antibodies on evolution of hypervariable region 1 during acute HCV infection.
Scottà C; Garbuglia AR; Ruggeri L; Spada E; Laurenti L; Perrone MP; Girelli G; Mele A; Capobianchi MR; Folgori A; Nicosia A; Del Porto P; Piccolella E;
J Hepatol; 2008 Feb; 48(2):216-28. PubMed ID: 18180071
[TBL] [Abstract][Full Text] [Related]
9. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
[TBL] [Abstract][Full Text] [Related]
10. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon.
Hattori M; Yoshioka K; Aiyama T; Iwata K; Terazawa Y; Ishigami M; Yano M; Kakumu S
Hepatology; 1998 Jun; 27(6):1703-10. PubMed ID: 9620346
[TBL] [Abstract][Full Text] [Related]
11. B-cell epitopes in hypervariable region 1 of hepatitis C virus obtained from patients with chronic persistent hepatitis.
Nakamoto Y; Kaneko S; Ohno H; Honda M; Unoura M; Murakami S; Kobayashi K
J Med Virol; 1996 Sep; 50(1):35-41. PubMed ID: 8890039
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hypervariable region 1-specific and -cross-reactive CD4(+) T cells in HCV-infected individuals responsive to IFN-alpha treatment.
Del Porto P; Puntoriero G; Scottà C; Nicosia A; Piccolella E
Virology; 2000 Apr; 269(2):313-24. PubMed ID: 10753710
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of mother-to-infant transmission of hepatitis C virus (HCV) infection. Study Group for Vertical Transmission.
Mazza C; Ravaggi A; Rodella A; Padula D; Duse M; Lomini M; Puoti M; Rossini A; Cariani E
J Med Virol; 1998 Jan; 54(1):12-9. PubMed ID: 9443104
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
[TBL] [Abstract][Full Text] [Related]
15. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
16. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus.
Zhou YH; Moriyama M; Esumi M
Virology; 1999 Apr; 256(2):360-70. PubMed ID: 10191201
[TBL] [Abstract][Full Text] [Related]
17. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]